Watchlist Manager

Watchlist

Price: 27.9 SAR 2.57% Market Closed

Market Cap: ﷼3.3B

	Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC SAU:2070	SA
U	Uniphar PLC ISEQ:UPR	IE
	Aohata Corp TSE:2830	JP
D	DoanXa Port JSC VN:DXP	VN
A	Alloggio Pty Ltd ASX:ALO	AU
	Kaplamin Ambalaj Sanayi ve Ticaret AS IST:KAPLM.E	TR
T	TDG Global Investment JSC VN:TDG	VN
	Obic Business Consultants Co Ltd TSE:4733	JP
Y	Yaizu Suisankagaku Industry Co Ltd TSE:2812	JP
	Shenzhen Cereals Holdings Co Ltd SZSE:000019	CN
Q	QubicGames SA WSE:QUB	PL
T	Twentyfirst Century Management Services Ltd NSE:21STCENMGM	IN
	Razer Inc HKEX:1337	US
T	Tailam Tech Construction Holdings Ltd HKEX:6193	CN
A	Aeon Hokkaido Corp TSE:7512	JP
	Cranswick PLC LSE:CWK	UK
	CHAPTERS Group AG XETRA:CHG	DE
	Bawan Company SJSC SAU:1302	SA
A	Alphabet Inc XETRA:ABEA	US
	Ride On Express Holdings Co Ltd TSE:6082	JP
	WiseTech Global Ltd ASX:WTC	AU
	OS Co Ltd TSE:9637	JP
	JSR Corp TSE:4185	JP
	Zhejiang Lante Optics Co Ltd SSE:688127	CN

Income Statement

Currency: SAR

	Dec-2003	Mar-2004	Jun-2004	Sep-2004	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(11)	0	0	0	0	0	0	0	5	0	0	0	1	0	0	0	11	0	0	0	34	0	0	0	74	0	0	0	96	1	1	1	0
Revenue	556 N/A	614 +10%	623 +1%	603 -3%	583 -3%	578 -1%	591 +2%	612 +4%	649 +6%	677 +4%	710 +5%	726 +2%	728 +0%	737 +1%	761 +3%	753 -1%	798 +6%	815 +2%	817 +0%	814 0%	872 +7%	909 +4%	927 +2%	952 +3%	951 0%	967 +2%	990 +2%	1 011 +2%	1 038 +3%	1 015 -2%	1 055 +4%	1 073 +2%	1 129 +5%	1 180 +5%	1 175 0%	1 193 +2%	1 183 -1%	1 241 +5%	1 299 +5%	1 295 0%	1 297 +0%	1 354 +4%	1 384 +2%	1 427 +3%	1 470 +3%	1 500 +2%	1 562 +4%	1 604 +3%	1 705 +6%	1 595 -6%	1 499 -6%	1 448 -3%	1 259 -13%	1 329 +6%	1 295 -3%	1 315 +2%	1 386 +5%	1 375 -1%	1 366 -1%	1 313 -4%	1 503 +14%	1 566 +4%	1 571 +0%	1 689 +7%	1 487 -12%	2 606 +75%	2 633 +1%	2 664 +1%	1 555 -42%	1 534 -1%	1 532 0%	1 471 -4%	1 460 -1%	1 392 -5%	1 377 -1%	1 422 +3%	1 422 0%	1 569 +10%	1 667 +6%	1 692 +1%	1 655 -2%	1 596 -4%	1 561 -2%	1 626 +4%	1 682 +3%	1 691 +1%	1 719 +2%	1 687 -2%	1 707 +1%
Gross Profit
Cost of Revenue	(381)	(428)	(422)	(393)	(368)	(347)	(356)	(361)	(378)	(389)	(410)	(420)	(419)	(429)	(458)	(448)	(471)	(480)	(474)	(462)	(509)	(537)	(548)	(576)	(531)	(537)	(542)	(548)	(551)	(524)	(541)	(538)	(569)	(590)	(567)	(579)	(565)	(591)	(611)	(601)	(595)	(624)	(639)	(667)	(676)	(686)	(730)	(776)	(856)	(778)	(709)	(649)	(546)	(599)	(591)	(623)	(682)	(695)	(687)	(625)	(895)	(993)	(1 052)	(1 137)	(989)	(1 638)	(1 614)	(1 619)	(865)	(899)	(875)	(864)	(840)	(730)	(767)	(835)	(855)	(931)	(966)	(948)	(952)	(893)	(864)	(878)	(845)	(878)	(888)	(870)	(874)
Gross Profit	175 N/A	186 +7%	201 +8%	210 +4%	215 +2%	231 +7%	235 +2%	251 +7%	271 +8%	289 +6%	300 +4%	306 +2%	308 +1%	307 0%	303 -1%	305 +1%	327 +7%	335 +3%	344 +2%	351 +2%	363 +3%	372 +2%	379 +2%	377 0%	420 +11%	430 +2%	449 +4%	462 +3%	486 +5%	491 +1%	514 +5%	535 +4%	561 +5%	590 +5%	608 +3%	614 +1%	619 +1%	650 +5%	688 +6%	694 +1%	702 +1%	731 +4%	745 +2%	761 +2%	795 +4%	814 +2%	832 +2%	828 0%	849 +2%	817 -4%	790 -3%	799 +1%	713 -11%	731 +3%	703 -4%	692 -2%	704 +2%	680 -4%	679 0%	688 +1%	609 -12%	573 -6%	519 -10%	552 +6%	498 -10%	968 +95%	1 020 +5%	1 044 +2%	690 -34%	636 -8%	657 +3%	607 -8%	620 +2%	662 +7%	609 -8%	587 -4%	567 -3%	638 +13%	701 +10%	744 +6%	703 -5%	703 +0%	697 -1%	748 +7%	837 +12%	814 -3%	830 +2%	817 -2%	833 +2%
Operating Income
Operating Expenses	(138)	(148)	(153)	(155)	(151)	(157)	(159)	(165)	(167)	(195)	(208)	(211)	(196)	(202)	(214)	(216)	(227)	(237)	(238)	(250)	(252)	(258)	(259)	(259)	(275)	(278)	(292)	(303)	(321)	(328)	(342)	(351)	(369)	(386)	(399)	(399)	(418)	(442)	(475)	(485)	(495)	(519)	(531)	(551)	(553)	(559)	(571)	(575)	(587)	(591)	(585)	(608)	(660)	(681)	(629)	(618)	(516)	(534)	(571)	(588)	(556)	(541)	(584)	(573)	(660)	(1 245)	(1 191)	(1 196)	(536)	(510)	(520)	(518)	(579)	(593)	(612)	(644)	(667)	(732)	(721)	(709)	(633)	(593)	(593)	(637)	(696)	(683)	(669)	(622)	(594)
Selling, General & Administrative	(133)	(148)	(153)	(155)	(146)	(158)	(159)	(166)	(160)	(184)	(191)	(195)	(189)	(197)	(214)	(216)	(219)	(236)	(236)	(247)	(244)	(254)	(256)	(256)	(267)	(277)	(291)	(303)	(314)	(328)	(342)	(351)	(362)	(386)	(399)	(399)	(411)	(442)	(475)	(485)	(487)	(519)	(531)	(551)	(545)	(559)	(571)	(575)	(555)	(560)	(545)	(563)	(629)	(658)	(608)	(592)	(479)	(461)	(503)	(520)	(505)	(553)	(593)	(585)	(631)	(1 098)	(1 053)	(1 053)	(493)	(508)	(514)	(521)	(516)	(570)	(592)	(630)	(605)	(674)	(649)	(631)	(618)	(615)	(610)	(646)	(593)	(636)	(624)	(579)	(515)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(24)	(33)	(41)	(48)	(30)	(31)	(31)	(37)	(33)	(39)	(38)	(34)	(35)	(39)	(40)	(40)	(8)	(31)	(25)	(25)	(15)	(11)	(11)	(5)	(3)	(9)	(8)	(12)	(38)	(53)	(62)	(65)	(37)	(46)	(48)	(54)	(66)	(72)	(74)	(75)	(51)
Depreciation & Amortization	(5)	0	0	0	(5)	0	0	0	(7)	0	0	0	(7)	0	0	0	(6)	0	0	0	(6)	0	0	0	(6)	0	0	0	(7)	0	0	0	(8)	0	0	0	(7)	0	0	0	(8)	0	0	0	(7)	0	0	0	(7)	0	0	0	(6)	0	0	0	(12)	0	0	0	(37)	0	0	0	(35)	0	0	0	(39)	0	0	0	(46)	0	0	0	(33)	0	0	0	(47)	0	0	0	(41)	0	0	0	(38)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	(12)	(17)	(17)	0	(5)	0	0	(1)	0	(3)	(2)	(2)	(2)	(3)	(3)	(1)	(1)	(1)	(0)	(0)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	3	6	7	10	11	9	(33)	(31)	(33)	20	52	50	52	13	(116)	(112)	(118)	11	9	5	8	(14)	(13)	(12)	(2)	8	(6)	(9)	(13)	69	68	65	63	4	26	29	32	9
Operating Income	37 N/A	39 +5%	49 +26%	55 +13%	64 +16%	73 +14%	76 +4%	85 +12%	104 +22%	93 -10%	92 -1%	95 +2%	113 +19%	106 -6%	89 -15%	89 0%	100 +13%	98 -2%	105 +7%	102 -3%	111 +9%	114 +3%	120 +5%	118 -2%	145 +23%	152 +5%	157 +3%	159 +1%	166 +4%	163 -2%	172 +6%	184 +7%	191 +4%	205 +7%	209 +2%	215 +3%	200 -7%	208 +4%	213 +3%	209 -2%	207 -1%	212 +2%	214 +1%	210 -2%	242 +15%	255 +5%	260 +2%	254 -3%	262 +3%	226 -14%	204 -10%	191 -6%	53 -72%	49 -7%	75 +51%	74 -1%	189 +155%	146 -23%	108 -26%	100 -7%	52 -48%	33 -37%	(65) N/A	(22) +66%	(163) -649%	(277) -71%	(172) +38%	(152) +12%	154 N/A	126 -19%	137 +9%	88 -36%	41 -54%	69 +68%	(3) N/A	(57) -1 794%	(100) -75%	(94) +6%	(20) +79%	34 N/A	71 +106%	110 +56%	105 -5%	111 +6%	141 +27%	131 -7%	162 +24%	195 +20%	238 +23%
Pre-Tax Income
Interest Income Expense	1	0	0	0	2	9	10	9	3	9	0	0	0	2	23	27	21	20	25	21	26	25	24	23	23	23	24	24	24	23	31	31	30	29	52	50	47	47	66	73	84	105	91	97	95	90	224	224	112	116	(67)	(80)	9	(6)	(17)	(16)	3	3	5	1	22	(32)	(30)	(38)	(41)	(58)	(51)	(30)	4	9	(5)	(13)	3	(21)	(23)	(25)	(25)	(24)	(30)	(47)	(48)	(69)	(62)	(55)	(76)	(60)	(68)	(71)	(57)
Non-Reccuring Items	(2)	0	0	0	(2)	0	0	0	(2)	0	0	0	(10)	0	0	0	(4)	0	0	(4)	(4)	(3)	(3)	1	(3)	(6)	(6)	(6)	(3)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16	16	16	263	294	294	294	0	0	0	0	0	0	0	0	(136)	0	0	0	0	0	0	0	(0)	0	0	0	0	0	0	(31)	(14)	(21)	(18)	18	7	26	21	26	24
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	9	8	9	9	7	0	1	(0)	(4)	1	6	7	8	8	7	6	12	13	13	13	3	2	2	2	2	2	2	2	3	3	4	3	5	5	7	7	4	5	5	5	(5)	(5)	(6)	(5)	2	2	1	1	1	(0)	(0)	0	0	(0)	(0)	(0)	0	(0)	0	0	0	4	(105)	(105)	(109)	(217)	(109)	(109)	0	(1)	(1)	(2)	(10)	0	0	1	(8)	0	0	0	(3)	(3)	(3)	(3)	0	0	0	0	0
Pre-Tax Income	44 N/A	47 +5%	57 +22%	64 +12%	71 +11%	83 +16%	87 +6%	95 +8%	101 +7%	104 +2%	99 -5%	102 +3%	111 +9%	114 +3%	119 +4%	122 +3%	130 +6%	132 +1%	143 +9%	132 -8%	136 +3%	138 +1%	143 +3%	144 +1%	166 +16%	170 +3%	176 +3%	179 +1%	189 +6%	189 N/A	207 +9%	219 +6%	227 +4%	239 +5%	268 +12%	272 +1%	251 -8%	260 +3%	284 +9%	286 +1%	286 +0%	312 +9%	299 -4%	302 +1%	339 +12%	347 +2%	486 +40%	479 -2%	376 -21%	359 -5%	153 -57%	127 -17%	326 +156%	337 +3%	351 +4%	352 +0%	192 -45%	149 -22%	113 -24%	101 -10%	74 -27%	5 -93%	(200) N/A	(165) +18%	(448) -172%	(552) -23%	(331) +40%	(290) +12%	159 N/A	133 -16%	130 -2%	73 -44%	34 -54%	48 +43%	(26) N/A	(82) -218%	(133) -62%	(118) +11%	(50) +58%	(44) +12%	5 N/A	17 +218%	21 +29%	72 +234%	72 +1%	96 +34%	115 +19%	149 +30%	206 +38%
Net Income
Tax Provision	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(44)	0	0	0	(43)	(59)	(64)	(65)	(26)	(22)	(19)	(25)	(30)	(45)	(52)	(56)	(44)	(37)	(29)	(29)	(12)	(18)	(27)	(23)	(26)	(27)	(22)	(20)	(45)	(43)	(39)	(52)	(40)	(29)	(42)	(31)	(9)
Income from Continuing Operations	44	47	57	64	71	83	87	95	101	104	99	102	111	114	119	122	130	132	143	132	136	138	143	144	166	170	176	179	189	189	207	219	227	239	268	272	251	260	284	286	286	312	299	302	339	347	486	479	376	359	153	127	282	293	307	308	149	89	48	37	49	(18)	(218)	(189)	(478)	(598)	(383)	(346)	115	96	101	44	21	30	(53)	(105)	(158)	(145)	(71)	(64)	(40)	(27)	(18)	20	32	68	73	117	197
Income to Minority Interest	(4)	(5)	(5)	(5)	(6)	(5)	(5)	(5)	(5)	(5)	(6)	(6)	(6)	(7)	(8)	(9)	(8)	(8)	(8)	(8)	(8)	(8)	(9)	(10)	(11)	(13)	(14)	(14)	(13)	(12)	(12)	(13)	(16)	(17)	(17)	(18)	(19)	(21)	(23)	(23)	(20)	(17)	(19)	(19)	(23)	(22)	(21)	(21)	(19)	(12)	(5)	(3)	(5)	(4)	(12)	(9)	(10)	(5)	13	4	26	23	19	30	44	57	50	52	15	13	16	12	8	9	13	12	6	1	(3)	(7)	(11)	(13)	(15)	(14)	(7)	(7)	(10)	(9)	(12)
Net Income (Common)	40 N/A	42 +5%	52 +24%	59 +13%	66 +11%	77 +18%	83 +7%	90 +8%	96 +7%	98 +2%	93 -5%	96 +3%	105 +9%	107 +2%	110 +3%	113 +2%	122 +8%	123 +1%	135 +9%	124 -8%	128 +3%	130 +1%	134 +3%	134 +0%	155 +16%	157 +2%	163 +3%	165 +1%	177 +7%	177 +0%	195 +10%	206 +6%	211 +3%	222 +5%	252 +13%	254 +1%	233 -8%	239 +3%	262 +10%	264 +1%	267 +1%	296 +11%	280 -5%	283 +1%	317 +12%	325 +3%	465 +43%	458 -2%	357 -22%	347 -3%	149 -57%	124 -16%	277 +123%	289 +4%	296 +2%	299 +1%	139 -54%	85 -39%	61 -28%	41 -33%	74 +82%	6 -93%	(200) N/A	(160) +20%	(440) -176%	(549) -25%	(341) +38%	(302) +12%	125 N/A	105 -16%	111 +6%	51 -54%	26 -49%	34 +27%	(44) N/A	(97) -119%	(165) -71%	(144) +13%	(75) +48%	(71) +5%	(51) +28%	(33) +35%	(22) +33%	11 N/A	25 +125%	60 +144%	59 -1%	109 +85%	184 +68%
EPS (Diluted)	0.38 N/A	0.4 +5%	0.5 +25%	0.56 +12%	0.63 +12%	0.74 +17%	0.79 +7%	0.86 +9%	0.92 +7%	0.94 +2%	0.89 -5%	0.92 +3%	1.01 +10%	1.02 +1%	1.06 +4%	1.08 +2%	1.17 +8%	1.18 +1%	1.29 +9%	1.19 -8%	1.23 +3%	1.25 +2%	1.28 +2%	1.28 N/A	1.46 +14%	1.31 -10%	1.35 +3%	1.37 +1%	1.47 +7%	1.47 N/A	1.62 +10%	1.72 +6%	1.76 +2%	1.86 +6%	2.1 +13%	2.12 +1%	1.94 -8%	1.99 +3%	2.15 +8%	2.2 +2%	2.22 +1%	2.47 +11%	1.62 -34%	2.35 +45%	2.64 +12%	2.7 +2%	3.87 +43%	3.81 -2%	2.98 -22%	2.88 -3%	1.23 -57%	1.03 -16%	2.31 +124%	2.41 +4%	2.47 +2%	2.5 +1%	1.16 -54%	0.71 -39%	0.51 -28%	0.34 -33%	0.62 +82%	0.05 -92%	-1.66 N/A	-1.33 +20%	-3.66 -175%	-4.57 -25%	-2.84 +38%	-2.51 +12%	1.03 N/A	0.87 -16%	0.92 +6%	0.42 -54%	0.22 -48%	0.28 +27%	-0.36 N/A	-0.8 -122%	-1.37 -71%	-1.2 +12%	-0.62 +48%	-0.59 +5%	-0.42 +29%	-0.27 +36%	-0.18 +33%	0.09 N/A	0.21 +133%	0.5 +138%	0.49 -2%	0.91 +86%	1.54 +69%

Income Statement Balance Sheet Cash Flow Statement

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070

Income Statement

Earnings Waterfall
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC

Income Statement
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC

See Also

Company

Help

Tools

Stocks

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC SAU:2070

Income Statement

Earnings Waterfall Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC

Income Statement Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC

See Also

Company

Help

Tools

Stocks

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070

Earnings Waterfall
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC

Income Statement
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC